Research Summary
The rabies vaccine is a preventive measure designed to protect individuals from rabies, a deadly viral infection that affects the central nervous system. Rabies is primarily transmitted through the bite of an infected animal, and once symptoms appear, the disease is almost always fatal. The rabies vaccine is administered to individuals at risk of exposure to the virus, such as those in high-risk professions (veterinarians, animal handlers), travelers to regions where rabies is prevalent, and individuals who may have been bitten by or exposed to potentially rabid animals. The vaccine stimulates the immune system to produce antibodies against the rabies virus, providing immunity and preventing the development of the disease if exposure occurs. The rabies vaccine is critical in both human and animal health efforts to control and prevent the spread of rabies, and post-exposure vaccination is often administered promptly if someone is bitten by an animal suspected of carrying the virus.
According to DIResearch's in-depth investigation and research, the global Rabies Vaccine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Rabies Vaccine include GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Changsheng, VACN, Prcmise, BCHT, Hissen etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Rabies Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Rabies Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Rabies Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Rabies Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Rabies Vaccine Include:
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Changsheng
VACN
Prcmise
BCHT
Hissen
Rabies Vaccine Product Segment Include:
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Rabies Vaccine Product Application Include:
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Rabies Vaccine Industry PESTEL Analysis
Chapter 3: Global Rabies Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Rabies Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Rabies Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Rabies Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Rabies Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Rabies Vaccine Market Overview 1.1 Product Definition and Statistical Scope 1.2 Rabies Vaccine Product by Type 1.2.1 Global Rabies Vaccine Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Vero Cell Rabies Vaccine 1.2.3 BHK 1.2.4 Chick Embryo Cell Rabies Vaccine 1.2.5 Others 1.3 Rabies Vaccine Product by Application 1.3.1 Global Rabies Vaccine Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Pre-exposure Prophylaxis 1.3.3 Post-exposure Prophylaxis 1.4 Global Rabies Vaccine Market Revenue and Sales Analysis 1.4.1 Global Rabies Vaccine Market Size Analysis (2019-2030) 1.4.2 Global Rabies Vaccine Market Sales Analysis (2019-2030) 1.4.3 Global Rabies Vaccine Market Sales Price Trend Analysis (2019-2030) 1.5 Rabies Vaccine Market Development Status and Trends 1.5.1 Rabies Vaccine Industry Development Status Analysis 1.5.2 Rabies Vaccine Industry Development Trends Analysis 2 Rabies Vaccine Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Rabies Vaccine Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Rabies Vaccine Market Analysis by Regions 4.1 Rabies Vaccine Overall Market: 2023 VS 2024 VS 2030 4.2 Global Rabies Vaccine Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Rabies Vaccine Revenue and Market Share by Region (2019-2024) 4.2.2 Global Rabies Vaccine Revenue Forecast by Region (2025-2030) 4.3 Global Rabies Vaccine Sales and Forecast Analysis (2019-2030) 4.3.1 Global Rabies Vaccine Sales and Market Share by Region (2019-2024) 4.3.2 Global Rabies Vaccine Sales Forecast by Region (2025-2030) 4.4 Global Rabies Vaccine Sales Price Trend Analysis (2019-2030) 5 Global Rabies Vaccine Market Size by Type and Application 5.1 Global Rabies Vaccine Market Size by Type 5.1.1 Global Rabies Vaccine Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Rabies Vaccine Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Rabies Vaccine Market Size by Application 5.2.1 Global Rabies Vaccine Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Rabies Vaccine Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Rabies Vaccine Market Size by Type 6.3.1 North America Rabies Vaccine Sales by Type (2019-2030) 6.3.2 North America Rabies Vaccine Revenue by Type (2019-2030) 6.4 North America Rabies Vaccine Market Size by Application 6.4.1 North America Rabies Vaccine Sales by Application (2019-2030) 6.4.2 North America Rabies Vaccine Revenue by Application (2019-2030) 6.5 North America Rabies Vaccine Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Rabies Vaccine Market Size by Type 7.3.1 Europe Rabies Vaccine Sales by Type (2019-2030) 7.3.2 Europe Rabies Vaccine Revenue by Type (2019-2030) 7.4 Europe Rabies Vaccine Market Size by Application 7.4.1 Europe Rabies Vaccine Sales by Application (2019-2030) 7.4.2 ? Europe Rabies Vaccine Revenue by Application (2019-2030) 7.5 Europe Rabies Vaccine Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Rabies Vaccine Market Size by Type 8.3.1 China Rabies Vaccine Sales by Type (2019-2030) 8.3.2 China Rabies Vaccine Revenue by Type (2019-2030) 8.4 China Rabies Vaccine Market Size by Application 8.4.1 China Rabies Vaccine Sales by Application (2019-2030) 8.4.2 China Rabies Vaccine Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Rabies Vaccine Market Size by Type 9.3.1 APAC (excl. China) Rabies Vaccine Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Rabies Vaccine Revenue by Type (2019-2030) 9.4 APAC (excl. China) Rabies Vaccine Market Size by Application 9.4.1 APAC (excl. China) Rabies Vaccine Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Rabies Vaccine Revenue by Application (2019-2030) 9.5 APAC (excl. China) Rabies Vaccine Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Rabies Vaccine Market Size by Type 10.3.1 Latin America Rabies Vaccine Sales by Type (2019-2030) 10.3.2 Latin America Rabies Vaccine Revenue by Type (2019-2030) 10.4 Latin America Rabies Vaccine Market Size by Application 10.4.1 Latin America Rabies Vaccine Sales by Application (2019-2030) 10.4.2 Latin America Rabies Vaccine Revenue by Application (2019-2030) 10.5 Latin America Rabies Vaccine Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Rabies Vaccine Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Rabies Vaccine Market Size by Type 11.3.1 Middle East & Africa Rabies Vaccine Sales by Type (2019-2030) 11.3.2 Middle East & Africa Rabies Vaccine Revenue by Type (2019-2030) 11.4 Middle East & Africa Rabies Vaccine Market Size by Application 11.4.1 Middle East & Africa Rabies Vaccine Sales by Application (2019-2030) 11.4.2 Middle East & Africa Rabies Vaccine Revenue by Application (2019-2030) 11.5 Middle East & Africa Rabies Vaccine Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Rabies Vaccine Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Rabies Vaccine Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Rabies Vaccine Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Rabies Vaccine Average Sales Price by Manufacturers (2020-2024) 12.2 Rabies Vaccine Competitive Landscape Analysis and Market Dynamic 12.2.1 Rabies Vaccine Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 GSK (Novartis) 13.1.1 GSK (Novartis) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 GSK (Novartis) Rabies Vaccine Product Portfolio 13.1.3 GSK (Novartis) Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Sanofi-Pasteur 13.2.1 Sanofi-Pasteur Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Sanofi-Pasteur Rabies Vaccine Product Portfolio 13.2.3 Sanofi-Pasteur Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Chengda 13.3.1 Chengda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Chengda Rabies Vaccine Product Portfolio 13.3.3 Chengda Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Yisheng 13.4.1 Yisheng Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Yisheng Rabies Vaccine Product Portfolio 13.4.3 Yisheng Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Changsheng 13.5.1 Changsheng Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Changsheng Rabies Vaccine Product Portfolio 13.5.3 Changsheng Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 VACN 13.6.1 VACN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 VACN Rabies Vaccine Product Portfolio 13.6.3 VACN Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Prcmise 13.7.1 Prcmise Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Prcmise Rabies Vaccine Product Portfolio 13.7.3 Prcmise Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 BCHT 13.8.1 BCHT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 BCHT Rabies Vaccine Product Portfolio 13.8.3 BCHT Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Hissen 13.9.1 Hissen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Hissen Rabies Vaccine Product Portfolio 13.9.3 Hissen Rabies Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Rabies Vaccine Industry Chain Analysis 14.2 Rabies Vaccine Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Rabies Vaccine Typical Downstream Customers 14.4 Rabies Vaccine Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support